When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed

Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder

(2012) L. Citrome   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

(2012) L. Citrome   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Why Do Some Depressed Outpatients Who Are in Remission According to the Hamilton Depression Rating Scale Not Consider Themselves to Be in Remission?

(2012) Mark Zimmerman et al.   JOURNAL OF CLINICAL PSYCHIATRY

Clinical Relevance of Treatments for Acute Bipolar Disorder: Balancing Therapeutic and Adverse Effects

(2011) Shefali Srivastava et al.   CLINICAL THERAPEUTICS

Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions?

(2010) T. A. Ketter et al.   ACTA PSYCHIATRICA SCANDINAVICA

Adjunctive Aripiprazole, Olanzapine, or Quetiapine for Major Depressive Disorder: An Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed

(2010) Leslie Citrome   POSTGRADUATE MEDICINE

Relative vs. absolute measures of benefit and risk: what’s the difference?

(2009) L. Citrome   ACTA PSYCHIATRICA SCANDINAVICA

Compelling or irrelevant? Using number needed to treat can help decide

(2008) L. Citrome   ACTA PSYCHIATRICA SCANDINAVICA

Antipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks

(2008) Leslie Citrome et al.   Expert Review of Neurotherapeutics